Have your own idea? Try our Stock Screener
UPDATED Dec 31, 2024
Discover Global Growth Stocks from around the world. Sorted by forecasted growth, these stocks have higher than expected earnings or sales growth compared to other companies.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
VEL | UK£0.27 | 3.8% | -26.0% | UK£14.4m | n/a | PB2.4x | E125.9% | 0% | Capital Goods | ||
PRS | €0.30 | -8.8% | 2.4% | €326.1m | n/a | PE-9.9x | E125.9% | n/a | Media | ||
TBNK | US$9.73 | 0.2% | -14.0% | US$83.9m | US$12.47 | PB0.3x | E125.9% | 0.4% | Banks | ||
BTC | UK£0.16 | 3.3% | 85.3% | UK£38.3m | n/a | PB25.5x | E125.9% | n/a | Software | ||
NAH | UK£0.72 | 5.9% | 18.0% | UK£34.2m | n/a | PE42.5x | E125.7% | 0% | Media | ||
AZTA | US$50.00 | -0.5% | -22.9% | US$2.3b | US$56.60 | PS3.5x | E125.6% | 0% | Pharmaceuticals & Biotech | ||
WRBY | US$24.21 | -5.9% | 62.5% | US$2.9b | US$22.23 | PS3.9x | E125.6% | n/a | Retail | ||
ZETA | US$17.99 | -4.0% | 114.2% | US$4.3b | US$37.77 | PS4.7x | E125.6% | n/a | Software | ||
RELL | US$14.03 | 2.3% | 7.9% | US$201.3m | US$15.50 | PS1x | E125.6% | 1.7% | Tech | ||
LSX | €3.12 | 7.6% | -6.6% | €18.1m | €6.20 | PB1.3x | E125.5% | 0% | Software | ||
A007810 | ₩9,120.00 | -5.3% | -57.7% | ₩234.4b | ₩14,000.00 | PB0.6x | E125.5% | n/a | Tech | ||
DTST | US$4.23 | 0% | 44.4% | US$29.3m | US$9.00 | PE185.1x | E125.2% | n/a | Software | ||
3704 | NT$39.70 | -0.9% | -21.2% | NT$16.0b | NT$47.50 | PE46.1x | E125.1% | 3.8% | Tech | ||
A394280 | ₩13,930.00 | 5.0% | -48.4% | ₩304.7b | ₩42,000.00 | PS11.3x | E125.0% | n/a | Semiconductors | ||
MMI | US$38.26 | -0.4% | -10.5% | US$1.5b | US$30.00 | PS2.4x | E124.9% | 1.3% | Real Estate Management and Development | ||
603103 | CN¥14.39 | -6.1% | -19.5% | CN¥9.1b | CN¥16.43 | PS4.5x | E124.8% | 1.7% | Media | ||
601933 | CN¥6.34 | 3.8% | 125.6% | CN¥56.6b | CN¥4.00 | PB9.8x | E124.8% | 0% | Consumer Retailing | ||
EXPI | US$11.51 | -2.6% | -28.2% | US$1.8b | US$15.75 | PB8.4x | E124.8% | 1.7% | Real Estate Management and Development | ||
DNTL | CA$8.29 | -0.2% | 15.9% | CA$1.6b | CA$12.08 | PS1.1x | E124.8% | n/a | Healthcare | ||
EVOK | US$4.42 | -9.8% | -64.2% | US$9.9m | US$18.00 | PS1.1x | E124.7% | n/a | Pharmaceuticals & Biotech | ||
688369 | CN¥20.07 | -10.5% | -40.1% | CN¥2.2b | CN¥24.50 | PS2.3x | E124.6% | 0.6% | Software | ||
688201 | CN¥8.83 | -9.8% | -32.4% | CN¥2.8b | CN¥8.80 | PS5.5x | E124.6% | 0.2% | Software | ||
ORN | US$7.33 | -5.5% | 51.8% | US$292.1m | US$11.33 | PB2x | E124.5% | n/a | Capital Goods | ||
497 | HK$0.085 | 0% | -11.5% | HK$782.8m | n/a | PB0.06x | E124.5% | 0% | Real Estate Management and Development |